학술논문

Neurodevelopmental delay in children exposed to maternal SARS-CoV-2 in-utero
Document Type
article
Source
Scientific Reports. 14(1)
Subject
Paediatrics
Biomedical and Clinical Sciences
Pediatric
Brain Disorders
Prevention
Infectious Diseases
Coronaviruses
Intellectual and Developmental Disabilities (IDD)
Clinical Research
Perinatal Period - Conditions Originating in Perinatal Period
Neurosciences
Conditions Affecting the Embryonic and Fetal Periods
Women's Health
Pregnancy
Emerging Infectious Diseases
Reproductive health and childbirth
Humans
Female
COVID-19
Child
Preschool
Infant
Male
Developmental Disabilities
SARS-CoV-2
Brazil
Pregnancy Complications
Infectious
Prenatal Exposure Delayed Effects
Adult
Neurodevelopmental Disorders
Child Development
Los Angeles
Language
Abstract
It is unclear if SARS CoV-2 infection during pregnancy is associated with adverse neurodevelopmental repercussions to infants. We assessed pediatric neurodevelopmental outcomes in children born to mothers with laboratory-confirmed SARS CoV-2 infection during pregnancy. Neurodevelopmental outcomes of in-utero exposed children were compared to that of pre-pandemic control children in Los Angeles (LA), CA, USA and Rio de Janeiro, Brazil. Bayley Scales of Infant and Toddler Development, 3rd edition (Bayley-III), the gold standard tool for evaluating neurodevelopment until 36 months of age and Ages and Stages Questionnaires (ASQ-3), a frequently used screening instrument for evaluating neurodevelopment in this same age group were the assessment tools used. Developmental delay (DD) was defined as having a score